Bacterial Biomarker Detection
Bacterial Biomarker Detection - Related Videos
03:04
Colorimetric Detection of a Bacterial Biomarker Using a Modified Litmus Test
0 Views •
2025
This video demonstrates a colorimetric E. coli detection method, involving an E. coli biomarker activating a DNAzyme, leading to cleavage of RNA linkage and detachment of a DNAzyme-urease conjugate. A subsequent colorimetric assay detects the E. coli biomarker through ammonia-induced pH changes.
07:32
A Capillary Electrophoresis Immunoassay for Protein Biomarker Detection
0 Views •
2025
This video demonstrates a capillary electrophoresis immunoassay protocol for detecting a protein biomarker associated with amyotrophic lateral sclerosis (ALS) from human blood platelets. Confirmation of the presence of the ALS biomarker protein is achieved through size-based separation of the platelet proteins followed by chemiluminescent detection.
09:30
Bacterial Detection & Identification Using Electrochemical Sensors
0 Views •
Cited by 6 •
2013
We describe an electrochemical sensor assay method for rapid bacterial detection and identification. The assay involves a sensor array functionalized with DNA oligonucleotide capture probes for ribosomal RNA (rRNA) species-specific sequences. Sandwich hybridization of target rRNA with the capture probe and a horseradish peroxidase-linked DNA oligonucleotide detector probe produces a measurable amperometric current.
03:08
Detecting Bacterial Contamination Using Magneto-fluorescent Nanosensors
0 Views •
2025
This video demonstrates a technique to detect bacterial contaminants in food and water samples using nanosensors. The target pathogenic bacteria are detected through a combination of magnetic relaxation and fluorescence emission modalities.
10:22
Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
0 Views •
Cited by 62 •
2016
High Frequency Oscillations (HFOs) have emerged as presurgical biomarkers for the identification of the epileptogenic zone in pediatric patients with medically refractory epilepsy. A methodology for the noninvasive recording, detection, and localization of HFOs with simultaneous scalp electroencephalography (EEG) and magnetoencephalography (MEG) is presented.
FAQs
Nucleic acids, proteins, and metabolites provide different molecular entry points for engineered detection systems. Nucleic acids can be processed through amplification, while proteins may be recognized through antibody binding and other targets can interact with bioreceptors. Selecting among these classes helps align the assay with the desired indication of bacterial presence, identity, or activity.
Performance depends on how effectively the system captures the target biomarker and distinguishes it from unrelated sample components. Engineering improvements therefore emphasize stronger target recognition, efficient signal generation, and careful sample processing. These factors influence whether the system can detect low levels, identify the relevant bacterium, and produce a dependable qualitative or quantitative result.
These approaches convert biomarker recognition into measurable signals through different mechanisms. Nucleic acid amplification increases the detectable signal from genetic material, antibody binding uses molecular recognition of protein targets, and bioreceptor-based sensing relies on a receptor interaction with its target. The choice affects which biomarker can be measured and how the detection system is engineered.
A typical workflow begins by processing the sample so the target biomarker becomes accessible, followed by capture or recognition of that target. The system then converts the recognition event into a measurable signal, using amplification, antibody binding, or a bioreceptor. Signal strength can subsequently support qualitative determination or quantitative analysis of the bacterial target.
The approach supports rapid diagnostics, environmental monitoring, food safety, and bioprocess control. In each setting, detecting a bacterial molecular signature can assist pathogen screening or provide earlier awareness of bacterial presence and activity. Engineering priorities such as portability, sensitivity, selectivity, and automation help adapt detection platforms to different operational requirements.
A detection signal can indicate whether a bacterial target is present and may also support conclusions about its identity or activity, depending on the biomarker selected. Signal strength enables qualitative or quantitative interpretation rather than simple visual confirmation alone. Integrated platforms can use these measurements for screening, monitoring, and earlier responses in applied settings.